FDA investigators audited the Oxygen Development - Palm Springs, FL, United States facility and issued 13 inspectional observations (via FDA 483) on 29 Mar 2013.
Add To Cart
- Category: Foods & Cosmetics / Human Drugs
- Number of Observations: 13
- Inspection end: 29 Mar 2013
- Location: Palm Springs, United States
- FEI: 3009461317